Nearly half of US GLP-1 users stray from their prescribed regimen, CDC finds
Researchers at the CDC have published a study in the Morbidity and Mortality Weekly Report showing how often Americans depart from their GLP-1 prescriptions. Using survey data from more than 8,000 US adults, collected in July and August 2025, they estimate 9.8 percent of adults used a GLP-1 receptor agonist in 2025, roughly 27 million people.
Of those users, 44 percent said they took the drug differently from how it was prescribed. That meant skipping doses, delaying refills or taking smaller doses than directed. More than half of those who changed their use pointed to cost or availability. Cost was cited by 58 percent of modifiers aged 14 to 39, against 20 percent of modifiers aged 65 or older.
At least 23 percent of users reported using a compounded version, and another 9 percent did not know whether theirs was compounded. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness or quality before sale. Among compounded users, 62 percent did not take the drug as prescribed, compared with 36 percent of brand-name users. A 2025 study of sites selling compounded GLP-1s found nearly 40 percent stated or implied FDA approval, and nearly 80 percent used brand names in advertising, which violates FDA standards.
For health and care, the finding is a reminder that a drug's existence is not the same as access to it. Demand is large, but price pushes patients toward rationing doses or toward products with no regulatory review. That erodes the benefit the drugs are meant to deliver and shifts risk onto patients, particularly younger ones.
Caveats matter here. The data are self-reported and now more than a year old. Compounded drugs are generally described as having higher rates of preparation errors and contamination, but this survey did not measure that. The authors say the safety and effectiveness of modified dosing still need study, and they call for research to inform clinical guidelines.
Source: Ars Technica
Many Minded